Skip to main content
Erschienen in: Reactions Weekly 1/2019

01.10.2019 | Case report

Omalizumab

Fever following off-label use: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

A 44-year-old woman developed fever during off-label treatment with omalizumab for atopic dermatitis. …
Literatur
Zurück zum Zitat Necas M, et al. Lack of omalizumab efficacy in severe atopic dermatitis with extremely elevated IgE levels: Two case reports and a literature review. Acta Dermatovenerologica Alpina, Pannonica et Adriatica 28: 89-92, No. 2, Jun 2019. Available from: URL: http://doi.org/10.15570/actaapa.2019.22 - Czech Republic Necas M, et al. Lack of omalizumab efficacy in severe atopic dermatitis with extremely elevated IgE levels: Two case reports and a literature review. Acta Dermatovenerologica Alpina, Pannonica et Adriatica 28: 89-92, No. 2, Jun 2019. Available from: URL: http://​doi.​org/​10.​15570/​actaapa.​2019.​22 - Czech Republic
Metadaten
Titel
Omalizumab
Fever following off-label use: case report
Publikationsdatum
01.10.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-69021-0

Weitere Artikel der Ausgabe 1/2019

Reactions Weekly 1/2019 Zur Ausgabe

Case report

Gentamicin

Case report

Cyclobenzaprine

Case report

Alteplase

Case report

Multiple drugs

Case report

Rivaroxaban